123 related articles for article (PubMed ID: 33333530)
1. Does Determining Tumor Markers from the Testicular Vein Enable Better Diagnosis and Prognosis?
Zauner T; Heidler S; Lusuardi L; Albrecht W; Wimpissinger F
Urol Int; 2021; 105(3-4):264-268. PubMed ID: 33333530
[TBL] [Abstract][Full Text] [Related]
2. Testicular Tumor Markers in the Spermatic Vein - Correlation to Pathology, Stage and Outcome.
Banner A; Lotterstätter M; Madersbacher S; Schauer I
Urology; 2021 Aug; 154():196-200. PubMed ID: 33878332
[TBL] [Abstract][Full Text] [Related]
3. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
4. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
5. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
Mumperow E; Kressel K; Hartmann M
Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in testicular cancer].
Mann K
Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
[TBL] [Abstract][Full Text] [Related]
7. [Surveillance of stage I testicular seminoma: 20 years oncological results].
Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
[TBL] [Abstract][Full Text] [Related]
8. Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors.
Gels ME; Marrink J; Visser P; Sleijfer DT; Droste JH; Hoekstra HJ; Andrews PW; Schraffordt Koops H
Ann Surg Oncol; 1997 Jun; 4(4):321-7. PubMed ID: 9181232
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
Tandstad T; Klepp O
Acta Oncol; 2003; 42(3):202-6. PubMed ID: 12852696
[TBL] [Abstract][Full Text] [Related]
10. Significance of placental alkaline phosphatase (PLAP) in the monitoring of patients with seminoma.
Koshida K; Uchibayashi T; Yamamoto H; Hirano K
Br J Urol; 1996 Jan; 77(1):138-42. PubMed ID: 8653285
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group.
Weissbach L; Bussar-Maatz R; Löhrs U; Schubert GE; Mann K; Hartmann M; Dieckmann KP; Fassbinder J
Eur Urol; 1999 Dec; 36(6):601-8. PubMed ID: 10559615
[TBL] [Abstract][Full Text] [Related]
12. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours?
Imamoglu GI; Eren T; Baylan B; Karacın C
Urol Int; 2019; 103(3):303-310. PubMed ID: 31466076
[TBL] [Abstract][Full Text] [Related]
13. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
14. The role of tumor size, ultrasonographic findings, and serum tumor markers in predicting the likelihood of malignant testicular histology.
Song G; Xiong GY; Fan Y; Huang C; Kang YM; Ji GJ; Chen JC; Xin ZC; Zhou LQ
Asian J Androl; 2019; 21(2):196-200. PubMed ID: 30648671
[TBL] [Abstract][Full Text] [Related]
15. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study.
Weissbach L; Bussar-Maatz R; Mann K
Eur Urol; 1997; 32(1):16-22. PubMed ID: 9266226
[TBL] [Abstract][Full Text] [Related]
16. Serum tumour markers in testicular and extragonadal germ cell malignancies.
Klepp O
Scand J Clin Lab Invest Suppl; 1991; 206():28-41. PubMed ID: 1947758
[TBL] [Abstract][Full Text] [Related]
17. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
[TBL] [Abstract][Full Text] [Related]
18. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma.
Fosså A; Fosså SD
Br J Urol; 1989 Apr; 63(4):408-15. PubMed ID: 2653557
[TBL] [Abstract][Full Text] [Related]
19. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
20. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
